0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover6936.41%IV-8.50%PremiumMay 17, 2024Expiry Date2.50Intrinsic Value100Multiplier-2DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type-0.6843Delta0.1316Gamma1.71Leverage Ratio-21.9525Theta0.0000Rho-1.17Eff Leverage0.0001Vega
Achieve Life Stock Discussion
NEWS
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
No comment yet